Literature DB >> 25180733

Response.

Gene L Colice1, Steven Idell2.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 25180733      PMCID： PMC4151363          DOI： 10.1378/chest.14-0920

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  8 in total

1.  Counterpoint: should fibrinolytics be routinely administered intrapleurally for management of a complicated parapneumonic effusion? No.

Authors:  Gene L Colice; Steven Idell
Journal:  Chest       Date:  2014-01       Impact factor: 9.410

2.  Point: should fibrinolytics be routinely administered intrapleurally for management of a complicated parapneumonic effusion? Yes.

Authors:  John P Corcoran; Najib M Rahman
Journal:  Chest       Date:  2014-01       Impact factor: 9.410

3.  Rebuttal from Drs Colice and Idell.

Authors:  Gene L Colice; Steven Idell
Journal:  Chest       Date:  2014-01       Impact factor: 9.410

4.  Rebuttal from Drs Corcoran and Rahman.

Authors:  John P Corcoran; Najib M Rahman
Journal:  Chest       Date:  2014-01       Impact factor: 9.410

5.  A double blind randomized cross over trial comparing rate of decortication and efficacy of intrapleural instillation of alteplase vs placebo in patients with empyemas and complicated parapneumonic effusions.

Authors:  G Thommi; J C Shehan; K L Robison; M Christensen; L A Backemeyer; M T McLeay
Journal:  Respir Med       Date:  2012-03-06       Impact factor: 3.415

6.  Effectiveness and risks associated with intrapleural alteplase by means of tube thoracostomy.

Authors:  Sharon Ben-Or; Richard H Feins; Nirmal K Veeramachaneni; Benjamin E Haithcock
Journal:  Ann Thorac Surg       Date:  2011-03       Impact factor: 4.330

7.  Efficacy and safety of intrapleural instillation of alteplase in the management of complicated pleural effusion or empyema.

Authors:  George Thommi; Chandra K Nair; Wilbert S Aronow; Chris Shehan; Patrick Meyers; Matthew McLeay
Journal:  Am J Ther       Date:  2007 Jul-Aug       Impact factor: 2.688

8.  Intrapleural use of tissue plasminogen activator and DNase in pleural infection.

Authors:  Najib M Rahman; Nicholas A Maskell; Alex West; Richard Teoh; Anthony Arnold; Carolyn Mackinlay; Daniel Peckham; Chris W H Davies; Nabeel Ali; William Kinnear; Andrew Bentley; Brennan C Kahan; John M Wrightson; Helen E Davies; Clare E Hooper; Y C Gary Lee; Emma L Hedley; Nicky Crosthwaite; Louise Choo; Emma J Helm; Fergus V Gleeson; Andrew J Nunn; Robert J O Davies
Journal:  N Engl J Med       Date:  2011-08-11       Impact factor: 91.245
  8 in total
  2 in total

1.  Inhibition of Glycogen Synthase Kinase 3β Blocks Mesomesenchymal Transition and Attenuates Streptococcus pneumonia-Mediated Pleural Injury in Mice.

Authors:  Jake Boren; Grant Shryock; Alexis Fergis; Ann Jeffers; Shuzi Owens; Wenyi Qin; Kathleen B Koenig; Yoshikazu Tsukasaki; Satoshi Komatsu; Mitsuo Ikebe; Steven Idell; Torry A Tucker
Journal:  Am J Pathol       Date:  2017-11       Impact factor: 4.307

2.  Precision-guided, Personalized Intrapleural Fibrinolytic Therapy for Empyema and Complicated Parapneumonic Pleural Effusions: The Case for the Fibrinolytic Potential.

Authors:  Steven Idell; Galina Florova; Sreerama Shetty; Torry Tucker; Richard Idell; Kathy Koenig; Ali Azghani; Najib M Rahman; Andrey Komissarov
Journal:  Clin Pulm Med       Date:  2017-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.